PLx Pharma Inc. (NASDAQ:PLXP) traded at $0.28 at close of the session on Monday, 01/23/23, made a downward move of -4.14% on its previous day’s price.
Looking at the stock we see that its previous close was $0.29 and the beta (5Y monthly) reads 3.90 with the day’s price range being $0.2705 – $0.3077. In terms of its 52-week price range, PLXP has a high of $6.66 and a low of $0.13. The company’s stock has gained about 54.44% over that past 30 days.
PLx Pharma Inc. has a market cap of $6.61 million and is expected to release its quarterly earnings report on Mar 09, 2023 – Mar 13, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$0.44, with the EPS growth for the year raised at -$1.65 for 2022 and -$1.26 for next year. These figures represent 19.90% and 23.60% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $1.3 million, with a low of $600k and a high of $2 million. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $6.45 million, or -21.40% down from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the PLXP stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is 38.09% off its SMA20 and 0.51% from its 50-day simple moving average. The RSI (14) is pointing at 59.71 while the volatility over the past week is 15.98% and jumps to 16.53% over the past one month. The beta value is 3.79, while the average true range (ATR) is currently pointing at 0.04.
Let’s briefly compare PLx Pharma Inc. (PLXP) stock to its peers. We find that current price change of -4.14% and -95.49% over the past 12 months for PLXP competes that of Perrigo Company plc (PRGO), which has seen its stock price rise 1.75% in the last trading session and was -6.49% over the last one year. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at 1.19% and 0.76%, respectively, at close of the trading.
Coming back to PLx Pharma Inc. (NASDAQ:PLXP), we note that the average 3-month trading volume was 376.55K, while that of the preceding 10-day period stands at 0.49 million. Current shares outstanding are 28.60 million.
The insiders hold 15.39% of the company’s shares while institutions hold 31.20%. The data shows that short shares as of Oct 13, 2022, stood at 0.3 million at a short ratio of 1.16. This represents a 1.03% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 0.68 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 69.41% up in year-to-date price movement.